Description: Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, safe medication guide gene testing for children and adults, disease genetic testing, disease susceptibility gene testing, etc.; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and experimental synthetic agents; and in vitro diagnostic reagents and medical devices. Vcanbio Cell & Gene Engineering Corp., Ltd was founded in 1992 and is based in Tianjin, the People's Republic of China.
Home Page: www.vcanbio.com
Huayuan Industrial Park
Tianjin,
300384
China
Phone:
86 22 5877 5766
Officers
Name | Title |
---|---|
Mr. Hongjia Gong | Actual Controller & Chairman |
Mr. Yong Wang | GM & Director |
Mr. Xu Li | Exec. Deputy GM & Director |
Mr. Hong Xiang Shi | Deputy Gen. Mang. |
Mr. Hai Bin Li | Deputy GM & Director |
Mr. Xin Zhe Yang | Deputy GM & Sec. |
Mr. Yu Zhang | Deputy GM and R&D Director |
Dr. Huang Jiaxue | Chief Technical Quality Officer |
Mr. Yueming Wang | Chief HR Officer |
Mr. YongJun Liu | Chief R&D Officer |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Biotechnology |
GIC Sub-Industry: | Biotechnology |
Forward PE: | 0 |
---|---|
Trailing PE: | 109.125 |
Price-to-Book MRQ: | 2.4664 |
Price-to-Sales TTM: | 5.5819 |
IPO Date: | 1992-08-18 |
Fiscal Year End: | December |
Full Time Employees: | 2231 |